The percentages of IFN-γ-producing CD134+CD4+ T-cells were significantly decreased in SLE patients as compared to HC (18.5 ± 11.5% vs. 29.2 ± 19.4%; p = 0.02, Fig. 1). This evidence concerns the gene TNFRSF4 and systemic lupus erythematosus.